Use of the PRECICE nail for distraction osteogenesis after tumor resection.
Intercalary defects
PRECICE nails
distraction osteosynthesis
intramedullary nail
limb lengthening
plate-assisted distraction osteosynthesis
Journal
Expert review of medical devices
ISSN: 1745-2422
Titre abrégé: Expert Rev Med Devices
Pays: England
ID NLM: 101230445
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
pubmed:
2
8
2022
medline:
24
8
2022
entrez:
1
8
2022
Statut:
ppublish
Résumé
Reconstructing long bone defects following intercalary tumor resection presents an exciting challenge with a greater range of surgical solutions than more typical situations requiring arthroplasty. Segmental bone transport (distraction osteogenesis) is the least utilized option for intercalary reconstruction; however, it arguably provides patients with the most desirable result. Distraction osteogenesis can be used in the management of multiple skeletal conditions including deformity (congenital or acquired), or in the presence of bone defects (by trauma or planned surgical excision). Lack of broader adoption of transport is likely due to the highly technical demands and common complications of utilizing fine-wire fixators via the Ilizarov method. More recently, internal lengthening nails such as the PRECICE nail have been employed to facilitate distraction osteogenesis without the added complexity of external fixation. This review will examine the literature on the indications, design, and safety of the PRECICE nail (NuVasive) for intercalary reconstruction after tumor resection. Bone transport using the PRECICE nail represents a viable alternative to Ilizarov distraction and has the benefit of avoiding the complications of an external fixator. For large defects, the PRECICE nail can be supplemented with a locking plate for additional stability and maintenance of limb length.
Identifiants
pubmed: 35912406
doi: 10.1080/17434440.2022.2108704
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM